BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 13, 2005
View Archived Issues
Levetiracetam improves chorea symptoms in patients with Huntington's disease
Read More
Ralfinamide induces analgesic effects in patients with neuropathic pain
Read More
VasoGenix and QLT to develop new treatment for congestive heart failure
Read More
CT-011 completes phase I study in advanced hematological malignancies
Read More
Intercell and Biological E sign Asia agreement for Japanese encephalitis vaccine
Read More
FDA clears phase I study of systemic administered Reolysin
Read More
AustCancer submits DMF for GPI-0100
Read More
Innovate Oncology acquires rights to Capridine-Beta for prostate cancer
Read More
BAL-5788 enters hospital-acquired pneumonia phase III trials
Read More
Fosamax Plus D receives FDA approval
Read More
Celgene completes Revlimid NDA submission for MDS
Read More
Eisai and Abbott to develop adalimumab for psoriasis in Japan
Read More
Bausch & Lomb discloses new therapeutic agents for ophthalmic diseases
Read More
Retisert receives FDA approval
Read More
New patents cover treatments for pain and inflammation
Read More
New data on the antiviral efficacy and the PK of celgosivir
Read More
Long-term effects of transdermal rotigotine in patients with early PD
Read More
A new study confirms the benefits of eszopiclone in chronic insomnia
Read More
Lasofoxifene induces no adverse effects on mood and cognition in postmenopausal women
Read More
Japanese manufacturing approval for tocilizumab for Castleman's disease
Read More
Japanese manufacturing approval for Lulicon
Read More
Promising results from in vitro and in vivo testing of human rhinovirus inhibitor
Read More
Prana will not advance PBT-1 into PLACQUE study
Read More
Long-acting naltrexone reduces heavy drinking in alcohol-dependent subjects
Read More
Phase III results on lucinactant in premature infants at risk for RDS
Read More